Already a well-established treatment for different autonomic and movement disorders, the
use of botulinum toxin type A (BoNT/A) in pain conditions is now continuously expanding …

Botulinum toxin (BoNT) has been used as a treatment for excessive muscle stiffness,
spasticity, and dystonia. BoNT for approximately 40 years, and has recently been used to …

Background Data from previous studies suggest that botulinum toxin A has analgesic effects
against peripheral neuropathic pain, but the quality of the evidence is low. We aimed to …

Objective To compare the effectiveness of diverse injections in patients with rotator cuff
tendinopathy using pairwise and network meta-analysis. Data Sources PubMed, EMBASE …

Botulinum neurotoxins (BoNTs) cause flaccid paralysis by interfering with vesicle fusion and
neurotransmitter release in the neuronal cells. BoNTs are the most widely used therapeutic …

Objective. To assess the benefits of subcutaneous injection of botulinum toxin A (BTX-A) for
the treatment of postherpetic neuralgia (PHN). Design. We investigated the therapeutic …

Botulinum neurotoxin (BoNT), derived from Clostridium botulinum, has been used
therapeutically for focal dystonia, spasticity, and chronic migraine. Its spectrum as a potential …

Botulinum toxin (BoNT) is an acetylcholine release inhibitor and a neuromuscular blocking
agent used for the treatment of a variety of neurologic and medical conditions. The efficacy …

Abstract Botulinum toxin A (BTX-A) is approved for treatment of different cholinergic
hyperactivity disorders, and, recently, migraine headache. Although suggested to act only …

Botulinum neurotoxin type A (BoNT/A) is one of the most potent toxins known and a potential
biological threat. At the same time, it is among the most widely used therapeutic proteins …